3654 results for «209»

Filter By

3654 results

TAVI abstracts

09 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the latest TAVI-related research and advancements. Explore studies on optimizing hemostasis during TAVI, the safety and efficacy of TAVI in Filipino patients, the outcomes of TAVI in hemodialysis patients, and the effectiveness of patient education videos for TAVI. Stay up-to-date with the latest developments...

TAVI abstracts

LAA closure

09 Feb 2025 – From PCR Tokyo Valves 2025

This session offers valuable insights into various aspects of left atrial appendage (LAA) closure, a critical procedure for stroke prevention in atrial fibrillation patients. Explore improvements to the safety checklist, case studies on left atrial thrombosis and mobile thrombus management, as well as a successful case...

LAA closure

Coronary access after TAVI: timing and techniques

09 Feb 2025 – From PCR Tokyo Valves 2025

Struggling with PCI after TAVI? This session breaks it down with 3 real-world cases. You'll learn when and how to perform revascularization in severe AS patients, the impact of commissure alignment on future coronary access, and expert techniques for post-TAVI PCI:

  • Case 1: Managing a patient with...
Coronary access after TAVI: timing and techniques

Expanding indications for TAVI - moderate aortic stenosis and heart failure

09 Feb 2025 – From PCR Tokyo Valves 2025

Should you intervene earlier in patients with moderate aortic stenosis and heart failure? This session breaks down the latest trials shaping clinical decisions.

You'll get the key takeaways from EARLY TAVR, EVOLVED, TAVR UNLOAD, PROGRESS and EXPAND TAVR II (what they reveal, what they don’t and how...

Expanding indications for TAVI - moderate aortic stenosis and heart failure

Complex anatomical features

09 Feb 2025 – From PCR Tokyo Valves 2025

Dive into a captivating session that explores complex anatomical features in interventional cardiology. Discover dynamic improvements in tricuspid valve coaptation and regurgitation post-TAVI, the overlooked threat of aortic stenosis hidden by mitral stenosis, marked improvement in left ventricular function after simultaneous TAVI and M-TEER, recognition of...

Complex anatomical features

TAVI burning issues

09 Feb 2025 – From PCR Tokyo Valves 2025

This comprehensive session delves into the 'burning issues' in TAVI, covering a wide range of topics. Discover the impact of catheter insertion on left ventricular pacing, the importance of the en-face view for coronary cannulation, comparisons of TAVI valve expansions, indications for left and right ventricular...

TAVI burning issues

Imaging in TAVI

09 Feb 2025 – From PCR Tokyo Valves 2025

This session delves into the latest advancements in imaging for TAVI, covering a range of topics. Discover insights into clinical outcomes in patients with very low-gradient severe aortic stenosis after TAVI, the influence of TAVI valve differences on long-term outcomes in left ventricular mass index, the...

Imaging in TAVI

Valvular interventions

09 Feb 2025 – From PCR Tokyo Valves 2025

Explore the latest insights and advancements in valvular interventions in this comprehensive session. Dive into the medical cost analysis of TAVR versus SAVR in Japanese dialysis patients, the long-term outcomes of Myval valve implantation in the pulmonary position, the comparative effectiveness of balloon aortic valvuloplasty techniques,...

Valvular interventions

SMT’s Hydra TAVR Valve demonstrates sustained safety, durability, and hemodynamic performance at 5 Years

19 Nov 2025

MASTER-DAPT: “the MASTER of high-bleeding risk trials”

28 Aug 2021

Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.

Luis Ortega-Paz

Author

Luis Ortega-Paz
ESC Congress 2021 - MASTER-DAPT : “the MASTER of high-bleeding risk trials”

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

HOST-EXAM:10-year follow-up of clopidogrel vs aspirin monotherapy in stable CAD after PCI with drug-eluting stent

30 Mar 2026

Nicola Ryan provides her take on the 10-year follow-up of the HOST-EXAM, which was presented by Hyo-Soo Kim at ACC.26 in New Orleans.

Nicola Ryan

Author

Nicola Ryan
10-year follow-up of clopidogrel vs aspirin monotherapy in stable coronary artery disease after percutaneous coronary intervention with drug-eluting stent

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
Didn’t find what you were looking for?